{"id":2926,"date":"2026-04-16T21:18:18","date_gmt":"2026-04-16T18:18:18","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2926"},"modified":"2026-04-16T21:21:56","modified_gmt":"2026-04-16T18:21:56","slug":"duchenne-muscular-dystrophy-treatment-access","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/duchenne-muscular-dystrophy-treatment-access\/","title":{"rendered":"Duchenne Kas Distrofisi Tedavisine Eri\u015fim: E\u015fitlik, Politika ve Hesap Verebilirlik Konusunda K\u00fcresel Bir Ba\u015far\u0131s\u0131zl\u0131k"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Duchenne kas distrofisi (DMD) art\u0131k yaln\u0131zca biyolojisiyle tan\u0131mlanan bir hastal\u0131k de\u011fildir. <strong>G\u00fcn\u00fcm\u00fczde bu durum, tedaviye kimlerin eri\u015febildi\u011fi ve kimlerin eri\u015femedi\u011fiyle de e\u015fit derecede tan\u0131mlanmaktad\u0131r.<\/strong> Gen terapisi, ekzon atlama ila\u00e7lar\u0131 ve multidisipliner bak\u0131m alanlar\u0131ndaki b\u00fcy\u00fck ilerlemelere ra\u011fmen, Duchenne kas distrofisi tedavisine eri\u015fim \u00fclkeler, sa\u011fl\u0131k sistemleri ve sosyoekonomik gruplar aras\u0131nda son derece e\u015fitsiz olmaya devam etmektedir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ger\u00e7ek \u015fu ki: baz\u0131 \u00e7ocuklar hareket kabiliyetini ve hayatta kalma s\u00fcresini uzatan en son teknoloji \u00fcr\u00fcn\u00fc tedaviler al\u0131rken, di\u011ferleri temel bak\u0131m standartlar\u0131ndan bile mahrum b\u0131rak\u0131l\u0131yor. Bu bilimsel bir s\u0131n\u0131rlama de\u011fil. <strong>Bu, fiyatland\u0131rma modelleri, politika ataleti ve k\u00fcresel sa\u011fl\u0131k e\u015fitsizlikleri taraf\u0131ndan \u015fekillendirilen sistemik bir ba\u015far\u0131s\u0131zl\u0131kt\u0131r.<\/strong><\/p>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>\u0130\u00e7indekiler<\/h2><nav><ul><li><a href=\"#what-is-duchenne-muscular-dystrophy\">Duchenne Kas Distrofisi Nedir?<\/a><\/li><li><a href=\"#the-current-landscape-of-duchenne-muscular-dystrophy-treatment-access\">Duchenne Musk\u00fcler Distrofi Tedavisine Eri\u015fimin Mevcut Durumu<\/a><\/li><li><a href=\"#why-duchenne-muscular-dystrophy-treatment-access-is-so-unequal\">Duchenne Kas Distrofisi Tedavisine Eri\u015fimin Neden Bu Kadar E\u015fitsiz Oldu\u011fu<\/a><\/li><li><a href=\"#pharmaceutical-companies-and-duchenne-muscular-dystrophy-treatment-access\">\u0130la\u00e7 \u015eirketleri ve Duchenne Kas Distrofisi Tedavisine Eri\u015fim<\/a><\/li><li><a href=\"#government-responsibility-in-duchenne-muscular-dystrophy-treatment-access\">Duchenne Kas Distrofisi Tedavisine Eri\u015fimde H\u00fck\u00fcmetin Sorumlulu\u011fu<\/a><\/li><li><a href=\"#the-role-of-dmd-associations-in-treatment-access\">DMD Derneklerinin Tedaviye Eri\u015fimdeki Rol\u00fc<\/a><\/li><li><a href=\"#families-and-the-burden-of-access\">Aileler ve Eri\u015fim Y\u00fck\u00fc<\/a><\/li><li><a href=\"#clinical-evidence-supporting-early-and-equitable-access\">Erken ve E\u015fit Eri\u015fimi Destekleyen Klinik Kan\u0131tlar<\/a><\/li><li><a href=\"#ethical-imperative-access-as-a-human-right\">Etik Zorunluluk: Eri\u015fim Bir \u0130nsan Hakk\u0131 Olarak<\/a><\/li><li><a href=\"#solutions-to-improve-duchenne-muscular-dystrophy-treatment-access\">Duchenne Musk\u00fcler Distrofi Tedavisine Eri\u015fimi \u0130yile\u015ftirmeye Y\u00f6nelik \u00c7\u00f6z\u00fcmler<\/a><\/li><li><a href=\"#final-thoughts\">Son D\u00fc\u015f\u00fcnceler<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-is-duchenne-muscular-dystrophy\">Duchenne Kas Distrofisi Nedir?<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"genetic-basis-and-disease-mechanism\">Genetik Temel ve Hastal\u0131k Mekanizmas\u0131<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Duchenne kas distrofisi, X kromozomunda bulunan distrofin genindeki mutasyonlardan kaynaklan\u0131r. Distrofinin yoklu\u011fu, ilerleyici kas dejenerasyonuna, kronik iltihaplanmaya ve nihayetinde kas dokusunun ya\u011f ve fibrozis ile yer de\u011fi\u015ftirmesine yol a\u00e7ar. Daha fazla bilgi i\u00e7in:\u00a0<a href=\"https:\/\/dmdwarrior.com\/tr\/what-is-duchenne\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne Nedir?<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"clinical-progression-and-outcomes\">Klinik \u0130lerleme ve Sonu\u00e7lar<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Semptomlar\u0131n ba\u015flang\u0131c\u0131: 2-5 ya\u015f aras\u0131<\/li>\n\n\n\n<li>Y\u00fcr\u00fcme yetene\u011finin kayb\u0131: ~10\u201312 y\u0131l<\/li>\n\n\n\n<li>Kardiyomiyopati ve solunum yetmezli\u011fi: ergenlik d\u00f6nemi<\/li>\n\n\n\n<li>Ya\u015fam beklentisi: Bak\u0131mla \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015fti, ancak hala s\u0131n\u0131rl\u0131.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19945913\/\" target=\"_blank\" rel=\"noopener\">Bushby ve di\u011ferlerine g\u00f6re.<\/a> (2010), erken m\u00fcdahale ve multidisipliner y\u00f6netim, hayatta kalma oran\u0131n\u0131 ve ya\u015fam kalitesini \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015ftirebilir.<br><br>Daha fazla bilgi edin: <a href=\"https:\/\/dmdwarrior.com\/tr\/life-expectancy-in-duchenne-muscular-dystrophy\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne Hastal\u0131\u011f\u0131nda Ya\u015fam Beklentisi<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"the-current-landscape-of-duchenne-muscular-dystrophy-treatment-access\">Duchenne Musk\u00fcler Distrofi Tedavisine Eri\u015fimin Mevcut Durumu<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"available-therapies\">Mevcut Terapiler<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Modern DMD tedavisi \u015funlar\u0131 i\u00e7erir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kortikosteroidler (standart tedavi)<\/li>\n\n\n\n<li>Kalp ve solunum deste\u011fi<\/li>\n\n\n\n<li>Ekzon atlama terapileri (mutasyona \u00f6zg\u00fc)<\/li>\n\n\n\n<li>Gen terapisi (geli\u015fmekte olan, y\u00fcksek maliyetli)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Daha fazla bilgi edin: <a href=\"https:\/\/dmdwarrior.com\/tr\/category\/care-guidelines\/\" target=\"_blank\" rel=\"noreferrer noopener\">DMD Bak\u0131m Rehberi<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"the-access-gap\">Eri\u015fim A\u00e7\u0131\u011f\u0131<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Tedaviler mevcut olsa da, eri\u015fim \u015fu fakt\u00f6rlere ba\u011fl\u0131d\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ulusal geri \u00f6deme politikalar\u0131<\/li>\n\n\n\n<li>Sa\u011fl\u0131k altyap\u0131s\u0131<\/li>\n\n\n\n<li>\u0130la\u00e7 fiyatland\u0131rmas\u0131 ve bulunabilirli\u011fi<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc, nadir hastal\u0131klar\u0131 k\u00fcresel sa\u011fl\u0131k e\u015fitli\u011finde en \u00e7ok ihmal edilen alanlardan biri olarak vurgulamaktad\u0131r.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"why-duchenne-muscular-dystrophy-treatment-access-is-so-unequal\">Duchenne Kas Distrofisi Tedavisine Eri\u015fimin Neden Bu Kadar E\u015fitsiz Oldu\u011fu<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"economic-barriers\">Ekonomik Engeller<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">DMD tedavileri, t\u0131p alan\u0131ndaki en pahal\u0131 tedaviler aras\u0131ndad\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ekson atlama ila\u00e7lar\u0131: $300.000\u2013$1M y\u0131ll\u0131k<\/li>\n\n\n\n<li><a href=\"https:\/\/dmdwarrior.com\/tr\/elevidys-gene-therapy-efficacy-in-dmd\/\" target=\"_blank\" rel=\"noreferrer noopener\">Gen terapisi: Tedavi ba\u015f\u0131na &gt;$2,9M<\/a><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bu maliyetler, \u00f6zellikle d\u00fc\u015f\u00fck ve orta gelirli \u00fclkelerde sistemik d\u0131\u015flanmaya yol a\u00e7maktad\u0131r.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"regulatory-fragmentation\">D\u00fczenleyici Par\u00e7alanma<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">ABD G\u0131da ve \u0130la\u00e7 \u0130daresi gibi kurumlar taraf\u0131ndan onayland\u0131ktan sonra bile:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ulusal onay s\u00fcre\u00e7leri gecikebilir.<\/li>\n\n\n\n<li>Geri \u00f6deme kararlar\u0131 y\u0131llar s\u00fcrebilir.<\/li>\n\n\n\n<li>Gecikmeler s\u0131ras\u0131nda hastalar tedavi edilmeden kal\u0131yor.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"geographic-inequality\">Co\u011frafi E\u015fitsizlik<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Kuzey Amerika ve Bat\u0131 Avrupa&#039;daki hastalar:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Klinik ara\u015ft\u0131rmalara eri\u015fim<\/li>\n\n\n\n<li>Erken onaylar alabilirler<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Ba\u015fka yerlerdeki hastalar:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Te\u015fhisin gecikmesiyle kar\u015f\u0131 kar\u015f\u0131ya kalmak<\/li>\n\n\n\n<li>Tamamen eri\u015fim eksikli\u011fi<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"pharmaceutical-companies-and-duchenne-muscular-dystrophy-treatment-access\">\u0130la\u00e7 \u015eirketleri ve Duchenne Kas Distrofisi Tedavisine Eri\u015fim<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"pricing-strategies-and-market-exclusivity\">Fiyatland\u0131rma Stratejileri ve Piyasa M\u00fcnhasiyeti<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">\u0130la\u00e7 \u015firketleri y\u00fcksek fiyatlar\u0131 \u015fu gerek\u00e7elerle hakl\u0131 \u00e7\u0131kar\u0131yor:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ar-Ge maliyetleri<\/li>\n\n\n\n<li>K\u00fc\u00e7\u00fck hasta pop\u00fclasyonlar\u0131<\/li>\n\n\n\n<li>\u0130novasyon riski<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Ancak kan\u0131tlar \u015funu g\u00f6steriyor:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kamu fonlar\u0131 genellikle erken a\u015fama ara\u015ft\u0131rmalar\u0131 destekler.<\/li>\n\n\n\n<li>Kar marjlar\u0131 \u00f6nemli olabilir.<\/li>\n\n\n\n<li><strong>Fiyatland\u0131rma stratejileri, maksimum eri\u015fim i\u00e7in de\u011fil, maksimum gelir i\u00e7in optimize edilmi\u015ftir.<\/strong><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"ethical-concerns\">Etik Kayg\u0131lar<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Hayat kurtaran tedavilerin fiyat\u0131 ula\u015f\u0131lamayacak kadar y\u00fcksek oldu\u011funda, sorun ekonomiden eti\u011fe d\u00f6n\u00fc\u015f\u00fcyor.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Var olan ancak eri\u015filemeyen bir tedavi, yenilik de\u011fil, d\u0131\u015flamad\u0131r.<\/p>\n<\/blockquote>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"what-pharmaceutical-companies-should-do\">\u0130la\u00e7 \u015eirketleri Ne Yapmal\u0131?<\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"implement-tiered-pricing\">Kademeli Fiyatland\u0131rmay\u0131 Uygulay\u0131n<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Fiyatland\u0131rmay\u0131 ulusal gelir seviyelerine g\u00f6re ayarlay\u0131n.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"expand-global-access-programs\">K\u00fcresel Eri\u015fim Programlar\u0131n\u0131 Geni\u015fletin<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">\u0130nsani ama\u00e7larla kullan\u0131m\u0131n belirli b\u00f6lgelerle s\u0131n\u0131rl\u0131 kalmamas\u0131n\u0131 sa\u011flay\u0131n.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"increase-transparency\">\u015eeffafl\u0131\u011f\u0131 Art\u0131r\u0131n<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Ger\u00e7ek Ar-Ge ve \u00fcretim maliyetlerini a\u00e7\u0131klay\u0131n.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"government-responsibility-in-duchenne-muscular-dystrophy-treatment-access\">Duchenne Kas Distrofisi Tedavisine Eri\u015fimde H\u00fck\u00fcmetin Sorumlulu\u011fu<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"budget-priorities\">B\u00fct\u00e7e \u00d6ncelikleri<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">H\u00fck\u00fcmetler savunmaya milyarlarca dolar ay\u0131r\u0131rken:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Nadir hastal\u0131klar i\u00e7in ayr\u0131lan fonlar h\u00e2l\u00e2 \u00e7ok az.<\/li>\n\n\n\n<li>Geri \u00f6deme sistemleri y\u00fcksek maliyetli tedavileri kapsam d\u0131\u015f\u0131 b\u0131rak\u0131yor.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bu durum kaynak k\u0131tl\u0131\u011f\u0131ndan de\u011fil, politika tercihlerinden kaynaklanmaktad\u0131r.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"policy-failures\">Politika Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Geciken geri \u00f6deme kararlar\u0131<\/li>\n\n\n\n<li>Ulusal nadir hastal\u0131k stratejilerinin eksikli\u011fi<\/li>\n\n\n\n<li>Yetersiz tarama programlar\u0131<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"what-governments-should-do\">H\u00fck\u00fcmetler Ne Yapmal\u0131?<\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"establish-rare-disease-funds\">Nadir Hastal\u0131klar Fonlar\u0131 Olu\u015fturun<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Y\u00fcksek maliyetli tedaviler i\u00e7in ayr\u0131lm\u0131\u015f b\u00fct\u00e7eler.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"accelerate-reimbursement-pathways\">Geri \u00d6deme S\u00fcre\u00e7lerini H\u0131zland\u0131r\u0131n<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Onay ve eri\u015fim aras\u0131ndaki gecikmeleri azalt\u0131n.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"implement-newborn-screening\">Yenido\u011fan Tarama Program\u0131n\u0131 Uygulay\u0131n<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Erken te\u015fhis, erken m\u00fcdahaleyi m\u00fcmk\u00fcn k\u0131lar.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"the-role-of-dmd-associations-in-treatment-access\">DMD Derneklerinin Tedaviye Eri\u015fimdeki Rol\u00fc<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"advocacy-achievements\">Savunuculuk Ba\u015far\u0131lar\u0131<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Hasta \u00f6rg\u00fctlerinin sahip oldu\u011fu \u00f6zellikler \u015funlard\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fark\u0131ndal\u0131\u011f\u0131n art\u0131r\u0131lmas\u0131<\/li>\n\n\n\n<li>Desteklenen ara\u015ft\u0131rma fonlar\u0131<\/li>\n\n\n\n<li>Etkilenen d\u00fczenleyici yollar<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"limitations-and-challenges\">S\u0131n\u0131rlamalar ve Zorluklar<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Baz\u0131 kurulu\u015flar \u015fu sorunlarla kar\u015f\u0131 kar\u015f\u0131ya:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>End\u00fcstri ile finansal ba\u011flar<\/li>\n\n\n\n<li>S\u0131n\u0131rl\u0131 politika etkisi<\/li>\n\n\n\n<li>Eri\u015fime k\u0131yasla fark\u0131ndal\u0131\u011fa a\u015f\u0131r\u0131 \u00f6nem verilmesi<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"what-associations-should-do\">Dernekler Ne Yapmal\u0131?<\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"strengthen-policy-advocacy\">Politika Savunuculu\u011funu G\u00fc\u00e7lendirin<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Odak noktam\u0131z\u0131 sistemik de\u011fi\u015fime kayd\u0131r\u0131n.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"maintain-independence\">Ba\u011f\u0131ms\u0131zl\u0131\u011f\u0131 Koruyun<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c7\u0131kar \u00e7at\u0131\u015fmalar\u0131ndan ka\u00e7\u0131n\u0131n.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"build-global-coalitions\">K\u00fcresel Koalisyonlar Kurun<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Uluslararas\u0131 savunuculuk \u00e7al\u0131\u015fmalar\u0131n\u0131 koordine edin.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Daha fazla bilgi edin: <a href=\"https:\/\/dmdwarrior.com\/tr\/dmd-donations-how-associations-use-donations\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne Kas Distrofisi (DMD) Derneklerinde Hesap Verebilirlik Krizi<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"families-and-the-burden-of-access\">Aileler ve Eri\u015fim Y\u00fck\u00fc<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"navigating-complex-systems\">Karma\u015f\u0131k Sistemlerde Gezinme<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Aileler \u015funlar\u0131 yapmal\u0131d\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Genetik raporlar\u0131 yorumlamak<\/li>\n\n\n\n<li>Tedaviyi savunmak<\/li>\n\n\n\n<li>G\u00fcvenli finansman<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"the-rise-of-crowdfunding\">Kitlesel Fonlaman\u0131n Y\u00fckseli\u015fi<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Bir\u00e7ok aile \u015funlara g\u00fcveniyor:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kamu ba\u011f\u0131\u015flar\u0131<\/li>\n\n\n\n<li>Sosyal medya kampanyalar\u0131<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu durum, ihtiya\u00e7tan ziyade g\u00f6r\u00fcn\u00fcrl\u00fc\u011fe dayal\u0131 e\u015fitsizlik yarat\u0131r.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"what-families-can-do\">Aileler Neler Yapabilir?<\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"collective-advocacy\">Kolektif Savunuculuk<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Seslerin daha geni\u015f kitlelere ula\u015fmas\u0131 i\u00e7in a\u011flara kat\u0131l\u0131n.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"demand-policy-change\">Politika De\u011fi\u015fikli\u011fi Talebi<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Hay\u0131r i\u015flerine odaklanmaktan, haklara odaklanmaya ge\u00e7in.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"clinical-evidence-supporting-early-and-equitable-access\">Erken ve E\u015fit Eri\u015fimi Destekleyen Klinik Kan\u0131tlar<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"key-studies\">Temel \u00c7al\u0131\u015fmalar<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong><a href=\"https:\/\/www.cell.com\/molecular-therapy-family\/molecular-therapy\/fulltext\/S1525-0016(20)30664-X\" target=\"_blank\" rel=\"noreferrer noopener\">Mendell JR ve di\u011ferleri (2020)<\/a><\/strong> \u2013 Gen terapisi i\u015flevsel iyile\u015fme g\u00f6steriyor<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/www.thelancet.com\/journals\/laneur\/article\/PIIS1474-4422(18)30024-3\/abstract\" target=\"_blank\" rel=\"noreferrer noopener\">Birnkrant DJ ve di\u011ferleri (2018)<\/a><\/strong> \u2013 \u00c7ok disiplinli bak\u0131m hayatta kalma oran\u0131n\u0131 art\u0131r\u0131r<\/li>\n\n\n\n<li><strong>Bushby K ve di\u011ferleri (2014)<\/strong> \u2013 Erken te\u015fhis ve tedavi hayati \u00f6nem ta\u015f\u0131r.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu \u00e7al\u0131\u015fmalar \u015funu do\u011frulamaktad\u0131r:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Tedaviye eri\u015fim, sonu\u00e7lar\u0131 do\u011frudan etkiler.<\/p>\n<\/blockquote>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"ethical-imperative-access-as-a-human-right\">Etik Zorunluluk: Eri\u015fim Bir \u0130nsan Hakk\u0131 Olarak<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Birle\u015fmi\u015f Milletler sa\u011fl\u0131\u011f\u0131 temel bir insan hakk\u0131 olarak kabul etmektedir. Ancak DMD&#039;de:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Eri\u015fim co\u011frafi konuma ba\u011fl\u0131d\u0131r.<\/li>\n\n\n\n<li>Tedavi, gelir durumuna ba\u011fl\u0131d\u0131r.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu \u00e7eli\u015fki, k\u00fcresel sa\u011fl\u0131k e\u015fitli\u011fini baltal\u0131yor.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"solutions-to-improve-duchenne-muscular-dystrophy-treatment-access\">Duchenne Musk\u00fcler Distrofi Tedavisine Eri\u015fimi \u0130yile\u015ftirmeye Y\u00f6nelik \u00c7\u00f6z\u00fcmler<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"global-pricing-reform\">K\u00fcresel Fiyatland\u0131rma Reformu<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kademeli fiyatland\u0131rma modelleri<\/li>\n\n\n\n<li>Uluslararas\u0131 m\u00fczakere \u00e7er\u00e7eveleri<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"public-private-partnerships\">Kamu-\u00d6zel Ortakl\u0131klar\u0131<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ara\u015ft\u0131rma ve eri\u015fim i\u00e7in ortak finansman<\/li>\n\n\n\n<li>Risk payla\u015f\u0131m anla\u015fmalar\u0131<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"expanded-clinical-trials\">Geni\u015fletilmi\u015f Klinik Denemeler<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Yeterince temsil edilmeyen b\u00f6lgelerin dahil edilmesi<\/li>\n\n\n\n<li>Altyap\u0131 yat\u0131r\u0131m\u0131<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"data-sharing-and-collaboration\">Veri Payla\u015f\u0131m\u0131 ve \u0130\u015fbirli\u011fi<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>K\u00fcresel kay\u0131tlar<\/li>\n\n\n\n<li>Ger\u00e7ek d\u00fcnya verilerinin toplanmas\u0131<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"final-thoughts\">Son D\u00fc\u015f\u00fcnceler<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>H\u00fck\u00fcmetler ekonomilerinin &quot;g\u00fc\u00e7l\u00fc&quot; oldu\u011funu defalarca iddia ederken, Duchenne kas distrofisi tedavisine eri\u015fimi g\u00fcvence alt\u0131na alam\u0131yorlarsa, bu \u00e7eli\u015fkiyi g\u00f6rmezden gelmek imkans\u0131zd\u0131r.<\/strong> Ekonomik g\u00fc\u00e7, yaln\u0131zca GSY\u0130H rakamlar\u0131yla, altyap\u0131 projeleriyle veya savunma harcamalar\u0131yla \u00f6l\u00e7\u00fclmez; bir sistemin en savunmas\u0131z vatanda\u015flar\u0131n\u0131 en \u00e7ok ihtiya\u00e7 duyuldu\u011fu anda koruyabilme yetene\u011fiyle \u00f6l\u00e7\u00fcl\u00fcr.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bir \u00fclke ila\u00e7 \u015firketleriyle s\u00fcrd\u00fcr\u00fclebilir fiyatland\u0131rma konusunda pazarl\u0131k yapam\u0131yorsa, yerli ara\u015ft\u0131rma ve \u00fcretime yat\u0131r\u0131m yapam\u0131yorsa ve hayat kurtaran tedaviler i\u00e7in etkili geri \u00f6deme yollar\u0131 olu\u015fturam\u0131yorsa, bu ge\u00e7ici bir s\u0131n\u0131rlama de\u011fil, yap\u0131sal bir zay\u0131fl\u0131kt\u0131r.<\/strong> Bu durum, y\u00f6netimde, politika tasar\u0131m\u0131nda ve stratejik \u00f6nceliklendirmede ya\u015fanan eksiklikleri ortaya koyuyor. Ger\u00e7ekten g\u00fc\u00e7l\u00fc bir devlet, ilerleyen bir hastal\u0131kla m\u00fccadele ederken aileleri hayatta kalmak i\u00e7in para toplamaya veya b\u00fcrokratik gecikmelerle bo\u011fu\u015fmaya b\u0131rakmaz.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ayn\u0131 \u015fekilde, uluslararas\u0131 koalisyonlar, ortak tedarik veya yenilik\u00e7i fiyatland\u0131rma anla\u015fmalar\u0131 yoluyla sekt\u00f6rle anlaml\u0131 bir diyalog kuramamak, yaln\u0131zca ekonomik k\u0131s\u0131tlamalar\u0131 de\u011fil, ayn\u0131 zamanda siyasi yetkinlik ve m\u00fczakere kapasitesi eksikli\u011fini de g\u00f6sterir. Sa\u011fl\u0131k politikas\u0131 izole bir alan de\u011fildir; bir h\u00fck\u00fcmetin kaynaklar\u0131 sonu\u00e7lara ne kadar etkili bir \u015fekilde d\u00f6n\u00fc\u015ft\u00fcrebildi\u011finin bir yans\u0131mas\u0131d\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ger\u00e7ek \u015fu ki, rahats\u0131z edici bir durum s\u00f6z konusu: E\u011fer bir sistem, bilinen ihtiya\u00e7 ve mevcut bilimsel verilere ra\u011fmen temel tedavilere eri\u015fimi sa\u011flayam\u0131yorsa, g\u00fc\u00e7l\u00fc oldu\u011funa dair iddialar\u0131 b\u00fcy\u00fck \u00f6l\u00e7\u00fcde retorikten ibarettir.<\/strong> Hesap verebilirlik olmadan g\u00fc\u00e7, markala\u015fmad\u0131r. E\u015fitlik olmadan b\u00fcy\u00fcme, dengesizliktir. Ve somut sa\u011fl\u0131k sonu\u00e7lar\u0131 olmadan y\u00f6netim, nihayetinde etkisiz bir y\u00f6netimdir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Duchenne kas distrofisi tedavisine eri\u015fim, kararl\u0131 politika eylemleri, b\u00fct\u00e7e tahsisi ve uluslararas\u0131 i\u015fbirli\u011fiyle desteklenen bir \u00f6ncelik haline gelene kadar, ekonomik ba\u015far\u0131 a\u00e7\u0131klamalar\u0131 bo\u015f kalacakt\u0131r.<strong>\u00c7\u00fcnk\u00fc \u00e7ocuklar\u0131n\u0131 koruyamayan bir sistem, g\u00fc\u00e7l\u00fc oldu\u011funu iddia edemez.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\">Hangi ila\u00e7 \u015firketlerinden, \u00fclkelerden ve DMD derneklerinden bahsetti\u011fimizi a\u00e7\u0131k\u00e7a anl\u0131yorsunuz.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Devam\u0131n\u0131 oku: <a href=\"https:\/\/dmdwarrior.com\/tr\/duchenne-muscular-dystrophy-treatment-cost\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne Kas Distrofisi Tedavi Maliyetleri Neden Kontrolden \u00c7\u0131kt\u0131?<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Duchenne muscular dystrophy (DMD) is no longer a condition defined solely by its biology. Today, it is equally defined by who can access treatment\u2014and who cannot. Despite major advances in gene therapy, exon-skipping drugs, and multidisciplinary care, Duchenne muscular dystrophy treatment access remains profoundly unequal across countries, healthcare systems, and socioeconomic groups. The reality is [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":7622,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[282],"tags":[229,261,232,685,262],"class_list":["post-2926","post","type-post","status-publish","format-standard","has-post-thumbnail","category-editorials","tag-dmd-associations","tag-dmd-families","tag-dmd-treatments","tag-drug-access","tag-ministry-of-health"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/2926","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=2926"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/2926\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/7622"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=2926"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=2926"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=2926"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}